Found: 4
Select item for more details and to access through your institution.
Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2364, doi. 10.1007/s10637-012-9800-3
- By:
- Publication type:
- Article
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01132-z
- By:
- Publication type:
- Article
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
- Published in:
- BMC Cancer, 2008, v. 8, p. 1, doi. 10.1186/1471-2407-8-100
- By:
- Publication type:
- Article